Clinical Trial

No Reduction Compared to Closed Reduction for Distal Radius Fractures in Patients Over 65 or Older

Study acronym: DISCLOSE
Recruiting
View on ClinicalTrials.gov →
Summary
DISCLOSE trial is a randomized controlled trial including 532 participants with low-energy distal radius fractures. The primary objective is to evaluate whether casting without prior closed reduction is equivalent to casting following closed reduction with respect to wrist-related pain and disability, as measured by the Patient-Rated Wrist Evaluation (PRWE) score at 12 months, in patients aged 65 years or older with a displaced distal radius fracture. * Primary endpoint will be PRWE at 12 months * Follow-up visits are scheduled at 3 and 12 months. 5-year follow-up will be considered as an exploratory endpoint
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-06-19; most recent amendment 2026-01-19.
Status change: Not Yet Recruiting → Recruiting 2025-08-06
Trial Details
NCT Number NCT07042139
Lead Sponsor Tampere University Hospital
Collaborators: Kuopio University Hospital, Viborg Regional Hospital, Karolinska University Hospital, Helsinki University Central Hospital, Tartu University Hospital, Pori Central Hospital, Oulu University Hospital
Conditions Distal Radius Fracture, Casting, Closed Reduction
Enrollment 532 participants
Start Date 2025-08-01
Primary Completion 2029-07-01 (estimated)
Study Completion 2033-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-21